Literature DB >> 17586594

The role of adipocytokines in insulin resistance in normal pregnancy: visfatin concentrations in early pregnancy predict insulin sensitivity.

George Mastorakos1, Georgios Valsamakis, Dimitrios C Papatheodorou, Ioannis Barlas, Alexandra Margeli, Anastasios Boutsiadis, Evangelia Kouskouni, Nikolaos Vitoratos, Apostolos Papadimitriou, Ioannis Papassotiriou, George Creatsas.   

Abstract

BACKGROUND: Throughout pregnancy maternal adipose tissue is metabolically active, producing adipocytokines involved in the process of insulin resistance. We explored the role of serum adipocytokines, including the newly identified adipocytokine visfatin, in the process of insulin resistance in normal pregnancy.
METHODS: We examined 80 pregnant nonobese, nondiabetic white women during the 3 trimesters of pregnancy. All study participants underwent anthropometric measurements, adipocytokine evaluation, and a 75-g oral glucose tolerance test. Homeostasis mathematical model assessment (HOMA-R), insulin sensitivity index (ISI), and indices of beta-cell secretion were calculated.
RESULTS: Maternal weight, percentage total body fat, hip circumference, and indices of beta-cell secretion increased significantly during the 3 trimesters, and HOMA-R and ISI increased and decreased, respectively, in the 3rd trimester. During early pregnancy, insulin resistance, beta-cell secretion, and weight correlated positively with leptin. During the 1st trimester, visfatin correlated negatively with percentage body fat and was the best positive predictor of 2nd trimester ISI. In the 2nd trimester, serum visfatin was the best negative predictor of percentage body fat.
CONCLUSIONS: During normal pregnancy of nonobese, nondiabetic women, adipose tissue increases, accompanied by a significant progressive increase of insulin resistance. Visfatin concentrations in the 1st trimester positively predict insulin sensitivity during the 2nd trimester. Body fat mass during 1st trimester of pregnancy is negatively associated with insulin sensitivity during the 2nd trimester and perhaps should be kept under control.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17586594     DOI: 10.1373/clinchem.2006.084731

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  22 in total

1.  Evidence for differential regulation of the adipokine visfatin in the maternal and fetal compartments in normal spontaneous labor at term.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Edi Vaisbuch; Sun Kwon Kim; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Pooja Mittal; Zhong Dong; Percy Pacora; Lami Yeo; Sonia S Hassan
Journal:  J Perinat Med       Date:  2010-05       Impact factor: 1.901

2.  Maternal leptin, adiponectin, resistin, visfatin and tumor necrosis factor-alpha in normal and gestational diabetes.

Authors:  Amani F H Noureldeen; Safaa Y Qusti; Madeha N Al-Seeni; Maram H Bagais
Journal:  Indian J Clin Biochem       Date:  2013-10-29

3.  Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?

Authors:  Shali Mazaki-Tovi; Roberto Romero; Sun Kwon Kim; Edi Vaisbuch; Juan Pedro Kusanovic; Offer Erez; Tinnakorn Chaiworapongsa; Francesca Gotsch; Pooja Mittal; Chia-Ling Nhan-Chang; Nandor Gabor Than; Ricardo Gomez; Jyh Kae Nien; Samuel S Edwin; Percy Pacora; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-08

4.  Maternal plasma concentration of the pro-inflammatory adipokine pre-B-cell-enhancing factor (PBEF)/visfatin is elevated in pregnant patients with acute pyelonephritis.

Authors:  Shali Mazaki-Tovi; Edi Vaisbuch; Roberto Romero; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Chia-Ling Nhan-Chang; Ricardo Gomez; Bo H Yoon; Lami Yeo; Pooja Mittal; Giovanna Ogge; Juan M Gonzalez; Sonia S Hassan
Journal:  Am J Reprod Immunol       Date:  2010-01-19       Impact factor: 3.886

5.  Maternal visfatin concentration in normal pregnancy.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Juan Pedro Kusanovic; Edi Vaisbuch; Offer Erez; Nandor Gabor Than; Tinnakorn Chaiworapongsa; Chia-Ling Nhan-Chang; Percy Pacora; Francesca Gotsch; Lami Yeo; Sun Kwon Kim; Samuel S Edwin; Sonia S Hassan; Pooja Mittal
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

6.  Visfatin concentration is decreased in women with gestational diabetes mellitus in the third trimester.

Authors:  M Akturk; A E Altinova; I Mert; U Buyukkagnici; A Sargin; M Arslan; N Danisman
Journal:  J Endocrinol Invest       Date:  2008-07       Impact factor: 4.256

7.  Comparison of serum maternal adiponectin concentrations in women with isolated intrauterine growth retardation and intrauterine growth retardation concomitant with pre-eclampsia.

Authors:  Barış Büke; Hasan Onur Topçu; Yaprak Engin-Üstün; Nuri Danışman
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-08-08

8.  Visfatin in human pregnancy: maternal gestational diabetes vis-à-vis neonatal birthweight.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Juan Pedro Kusanovic; Edi Vaisbuch; Offer Erez; Nandor Gabor Than; Tinnakorn Chaiworapongsa; Chia-Ling Nhan-Chang; Percy Pacora; Francesca Gotsch; Lami Yeo; Sun Kwon Kim; Samuel S Edwin; Sonia S Hassan; Pooja Mittal
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

9.  Visfatin/Pre-B cell colony-enhancing factor in amniotic fluid in normal pregnancy, spontaneous labor at term, preterm labor and prelabor rupture of membranes: an association with subclinical intrauterine infection in preterm parturition.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Juan Pedro Kusanovic; Offer Erez; Francesca Gotsch; Pooja Mittal; Nandor Gabor Than; Chia-Lang Nhan-Chang; Neil Hamill; Edi Vaisbuch; Tinnakorn Chaiworapongsa; Samuel S Edwin; Jyh Kae Nien; Ricardo Gomez; Jimmy Espinoza; Claire Kendal-Wright; Sonia S Hassan; Gillian Bryant-Greenwood
Journal:  J Perinat Med       Date:  2008       Impact factor: 1.901

10.  Hormonal and metabolic factors associated with variations in insulin sensitivity in human pregnancy.

Authors:  H David McIntyre; Allan M Chang; Leonie K Callaway; David M Cowley; Alan R Dyer; Tatjana Radaelli; Kristen A Farrell; Larraine Huston-Presley; Saeid B Amini; John P Kirwan; Patrick M Catalano
Journal:  Diabetes Care       Date:  2009-10-30       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.